Home/Pipeline/Abeta mAb

Abeta mAb

Alzheimer's Disease

Pre-clinicalActive

Key Facts

Indication

Alzheimer's Disease

Phase

Pre-clinical

Status

Active

Company

Manifold Bio

About Manifold Bio

Manifold Bio is a private, preclinical-stage biotech based in Cambridge, MA, founded in 2019. The company has developed a unique platform that integrates AI-guided protein design with direct, high-throughput in vivo testing to engineer biologics with precise tissue-targeting properties. Its initial pipeline focuses on CNS-targeted therapies for Alzheimer's and Parkinson's diseases, with a broader vision to build a 'virtual organism' predictive model. The company is backed by notable investors and has entered a strategic collaboration with Roche.

View full company profile

Therapeutic Areas

Alzheimer's Disease Parkinson's Disease Cardiometabolic Disease

Other Alzheimer's Disease Drugs

Drug	Company	Phase	Status
NUZ-001	Neurizon Therapeutics	Preclinical	Active
ALZN002	Alzamend Neuro	Preclinical	Research
P021	Phanes Biotech	Preclinical	Active
PB43D	Phanes Biotech	Preclinical	Active
UB-311	Vaxxinity	Phase 2	Active
Lecanemab	BioArctic	Launched	Active (Commercial)
BAN2401	BioArctic	Preclinical	Active
Undisclosed Programs	johnson-and-johnson-innovative-medicine	Pipeline	Active
MK-6240 (florquinitau)	Lantheus Medical Imaging	Regulatory Filing	Filed
NAV-4694 (flutafuranol)	Lantheus Medical Imaging	Phase 3	Active
LNTH-2620/PI-2620	Lantheus Medical Imaging	Phase 3	Recruiting
itMSCs	Stemedica Cell Technologies	Clinical Development	Active